These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28945480)

  • 1. Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant Monitoring.
    Burnham P; Khush K; De Vlaminck I
    Ann Am Thorac Soc; 2017 Sep; 14(Supplement_3):S237-S241. PubMed ID: 28945480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free DNA diagnostics in transplantation utilizing next generation sequencing.
    Jackson AM; Amato-Menker C; Bettinotti M
    Hum Immunol; 2021 Nov; 82(11):850-858. PubMed ID: 34600770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation.
    Sherwood K; Weimer ET
    J Immunol Methods; 2018 Dec; 463():27-38. PubMed ID: 30267663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
    Kataria A; Kumar D; Gupta G
    Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition.
    Oellerich M; Christenson RH; Beck J; Schütz E; Sherwood K; Price CP; Keown PA; Walson PD
    J Appl Lab Med; 2020 Sep; 5(5):993-1004. PubMed ID: 32447378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation.
    Dengu F
    Transplant Rev (Orlando); 2020 Jul; 34(3):100542. PubMed ID: 32265093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches.
    Edwards RL; Menteer J; Lestz RM; Baxter-Lowe LA
    Biomark Med; 2022 Apr; 16(5):401-415. PubMed ID: 35195028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Noninvasive and Donor-independent Method Simultaneously Monitors Rejection and Infection in Patients With Organ Transplant.
    Zhou Y; Yang G; Liu H; Chen Y; Li X; Ge J; Wang X; Niu H; Dong W; Jiang T; Shi H; Peng L; Liu L
    Transplant Proc; 2019; 51(6):1699-1705. PubMed ID: 31399160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of graft-derived cell-free DNA for solid organ transplantation.
    Zhang W; Liu B; Jia D; Wang R; Cao H; Wu H; Ye Z; Gao B
    Front Immunol; 2024; 15():1461480. PubMed ID: 39376561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability.
    North PE; Ziegler E; Mahnke DK; Stamm KD; Thomm A; Daft P; Goetsch M; Liang HL; Baker MA; Vepraskas A; Rosenau C; Dasgupta M; Simpson P; Mitchell ME; Tomita-Mitchell A
    PLoS One; 2020; 15(1):e0227385. PubMed ID: 31929557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific circulating cell free DNA as a noninvasive biomarker of graft injury in heart transplantation.
    Macher HC; García-Fernández N; Adsuar-Gómez A; Porras-López M; González-Calle A; Noval-Padillo J; Guerrero JM; Molinero P; Borrego-Domínguez JM; Herruzo-Avilés Á; Rubio A
    Clin Chim Acta; 2019 Aug; 495():590-597. PubMed ID: 31175849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ Transplantation.
    Raszeja-Wyszomirska J; Macech M; Kolanowska M; Krawczyk M; Nazarewski S; Wójcicka A; Małyszko J
    Ann Transplant; 2023 Aug; 28():e939750. PubMed ID: 37580899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation.
    Filippone EJ; Farber JL
    Transplantation; 2021 Mar; 105(3):509-516. PubMed ID: 32732615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-specific Cell-free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review.
    Knight SR; Thorne A; Lo Faro ML
    Transplantation; 2019 Feb; 103(2):273-283. PubMed ID: 30308576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome.
    Jimenez-Coll V; Llorente S; Boix F; Alfaro R; Galián JA; Martinez-Banaclocha H; Botella C; Moya-Quiles MR; Muro-Pérez M; Minguela A; Legaz I; Muro M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
    Hurkmans DP; Verhoeven JGHP; de Leur K; Boer K; Joosse A; Baan CC; von der Thüsen JH; van Schaik RHN; Mathijssen RHJ; van der Veldt AAM; Hesselink DA
    J Immunother Cancer; 2019 Jul; 7(1):182. PubMed ID: 31300068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsies to Monitor Solid Organ Transplant Function: A Review of New Biomarkers.
    Verhoeven JGHP; Boer K; Van Schaik RHN; Manintveld OC; Huibers MMH; Baan CC; Hesselink DA
    Ther Drug Monit; 2018 Oct; 40(5):515-525. PubMed ID: 29957668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients.
    Zhao D; Zhou T; Luo Y; Wu C; Xu D; Zhong C; Cong W; Liu Q; Zhang J; Xia Q
    Sci Rep; 2021 Jan; 11(1):1138. PubMed ID: 33441886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients.
    Dale BL; Bose S; Kuo S; Burns A; Daou P; Short J; Miles J
    JMIR Res Protoc; 2021 Mar; 10(3):e25941. PubMed ID: 33720033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.